Brannan Stephen K.'s Form 4 filing
Karuna Therapeutics, Inc. (KRTX) · filed Nov 3, 2021
- Accession no.
- 0001593968-21-002356
- Filed
- Nov 3, 2021
- Trade date
- Nov 1, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.06M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brannan Stephen K.CIK 0001777631 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +2,500 | $5.45 | +$13,625 | 17,500 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +103 | $7.27 | +$748.81 | 17,603 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −103 | $136.67 | −$14,077.01 | 17,500 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +7,625 | $5.45 | +$41,556.25 | 25,125 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −7,625 | $136.67 | −$1,042,108.75 | 17,500 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 56,329 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −103 | $0.00 | $0 | 48,030 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −7,625 | $0.00 | $0 | 48,704 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.